When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
Today, we revisit biopharma concern Supernus Pharmaceuticals whose just reported 4th quarter results that triggered a near 10% selloff in its stock.
However, the company reported solid results for the quarter and year and navigated the impacts of the pandemic quite well in 2020.
Investors seem to be overlooking the potential FDA approval of another drug for the company's pipeline in 2021 as well as a huge cash hoard on its balance sheet.
We update our investment analysis on Supernus Pharmaceuticals in the paragraphs that follow.